R F Hoedemaeker

Summary

Affiliation: Erasmus University
Country: The Netherlands

Publications

  1. ncbi request reprint Comparison of pathologic characteristics of T1c and non-T1c cancers detected in a population-based screening study, the European Randomized Study of Screening for Prostate Cancer
    R F Hoedemaeker
    Department of Pathology, Erasmus University Rotterdam, The Netherlands
    World J Urol 15:339-45. 1997
  2. ncbi request reprint Pathologic features of prostate cancer found at population-based screening with a four-year interval
    R F Hoedemaeker
    Department of Pathology, Erasmus University Rotterdam, The Netherlands
    J Natl Cancer Inst 93:1153-8. 2001
  3. ncbi request reprint Consistency of prostate cancer grading results in screened populations across Europe
    T H Van der Kwast
    Department of Pathology, Josephine Nefkens Institute, Erasmus Medical Center, Rotterdam, The Netherlands
    BJU Int 92:88-91. 2003
  4. ncbi request reprint Tumor characteristics in screening for prostate cancer with and without rectal examination as an initial screening test at low PSA (0.0-3.9 ng/ml)
    A N Vis
    Department of Pathology, Josephine Nefkens Institute, Erasmus University, Rotterdam, The Netherlands
    Prostate 47:252-61. 2001
  5. pmc Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies : early cancers may contain aggressive genetic features
    J C Alers
    Department of Pathology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
    Am J Pathol 158:399-406. 2001
  6. ncbi request reprint The clinical significance of a small focus of well-differentiated carcinoma at prostate biopsy
    R F Hoedemaeker
    Department of Pathology, Josephine Nefkens Institute, Erasmus MC, Rotterdam, The Netherlands
    BJU Int 92:92-6. 2003
  7. ncbi request reprint Defining the window of opportunity in screening for prostate cancer: validation of a predictive tumor classification model
    A N Vis
    Department of Pathology, Josephine Nefkens Institute, Erasmus University, P O Box 1738, 3000 DR Rotterdam, The Netherlands
    Prostate 46:154-62. 2001
  8. ncbi request reprint Features of prostate cancers detected during a prevalence screening round. The Rotterdam experience
    Th H van der Kwast
    Department of Pathology, Erasmus MC, Rotterdam, The Netherlands and PATHAN Foundation, Rotterdam, The Netherlands
    Can J Urol 12:16-20. 2005
  9. ncbi request reprint Staging prostate cancer
    R F Hoedemaeker
    Department of Pathology, Erasmus University, 3000 DR Rotterdam, The Netherlands
    Microsc Res Tech 51:423-9. 2000
  10. ncbi request reprint The predictive value for prostate cancer of lesions that raise suspicion of concomitant carcinoma: an evaluation from a randomized, population-based study of screening for prostate cancer
    A N Vis
    Department of Pathology, Josephine Nefkens Institute, Erasmus University, 3000 DR Rotterdam, The Netherlands
    Cancer 92:524-34. 2001

Collaborators

Detail Information

Publications13

  1. ncbi request reprint Comparison of pathologic characteristics of T1c and non-T1c cancers detected in a population-based screening study, the European Randomized Study of Screening for Prostate Cancer
    R F Hoedemaeker
    Department of Pathology, Erasmus University Rotterdam, The Netherlands
    World J Urol 15:339-45. 1997
    ..Long-term follow-up, however, is necessary to substantiate this view...
  2. ncbi request reprint Pathologic features of prostate cancer found at population-based screening with a four-year interval
    R F Hoedemaeker
    Department of Pathology, Erasmus University Rotterdam, The Netherlands
    J Natl Cancer Inst 93:1153-8. 2001
    ..Our goal was to determine if a longer interval would compromise the detection of curable prostate cancer...
  3. ncbi request reprint Consistency of prostate cancer grading results in screened populations across Europe
    T H Van der Kwast
    Department of Pathology, Josephine Nefkens Institute, Erasmus Medical Center, Rotterdam, The Netherlands
    BJU Int 92:88-91. 2003
    ..Currently, tumour stage and grade in prostatectomy specimens represent the most predictive variables for biological behaviour. In prostate needle biopsies the tumour grade is a strong factor for deciding therapy...
  4. ncbi request reprint Tumor characteristics in screening for prostate cancer with and without rectal examination as an initial screening test at low PSA (0.0-3.9 ng/ml)
    A N Vis
    Department of Pathology, Josephine Nefkens Institute, Erasmus University, Rotterdam, The Netherlands
    Prostate 47:252-61. 2001
    ..The value of rectal examination as initial screening test for prostate cancer at low PSA values (0.0-3.9 ng/ml) was determined by evaluating the number and tumor characteristics of the cancers detected...
  5. pmc Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies : early cancers may contain aggressive genetic features
    J C Alers
    Department of Pathology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
    Am J Pathol 158:399-406. 2001
    ..Finally, early localized tumors, as detected by screening programs, harbor cancers with aggressive genetic characteristics...
  6. ncbi request reprint The clinical significance of a small focus of well-differentiated carcinoma at prostate biopsy
    R F Hoedemaeker
    Department of Pathology, Josephine Nefkens Institute, Erasmus MC, Rotterdam, The Netherlands
    BJU Int 92:92-6. 2003
    ....
  7. ncbi request reprint Defining the window of opportunity in screening for prostate cancer: validation of a predictive tumor classification model
    A N Vis
    Department of Pathology, Josephine Nefkens Institute, Erasmus University, P O Box 1738, 3000 DR Rotterdam, The Netherlands
    Prostate 46:154-62. 2001
    ..We investigated whether categorization of prostate cancers into different prognostic subgroups is feasible...
  8. ncbi request reprint Features of prostate cancers detected during a prevalence screening round. The Rotterdam experience
    Th H van der Kwast
    Department of Pathology, Erasmus MC, Rotterdam, The Netherlands and PATHAN Foundation, Rotterdam, The Netherlands
    Can J Urol 12:16-20. 2005
    ..Prostate-specific antigen (PSA) testing of asymptomatic men may lead to the detection of "minimal" prostate cancers that are less likely to be associated with morbidity or mortality...
  9. ncbi request reprint Staging prostate cancer
    R F Hoedemaeker
    Department of Pathology, Erasmus University, 3000 DR Rotterdam, The Netherlands
    Microsc Res Tech 51:423-9. 2000
    ..Follow-up data obtained from a group of 123 patients that underwent radical prostatectomy at our hospital underline the importance of reporting the latter two...
  10. ncbi request reprint The predictive value for prostate cancer of lesions that raise suspicion of concomitant carcinoma: an evaluation from a randomized, population-based study of screening for prostate cancer
    A N Vis
    Department of Pathology, Josephine Nefkens Institute, Erasmus University, 3000 DR Rotterdam, The Netherlands
    Cancer 92:524-34. 2001
    ..The authors assessed whether diagnostic follow-up of men with an initial diagnosis of isolated, high-grade prostatic intraepithelial neoplasia (HPIN) and a prostate biopsy suspicious for malignancy (PBSM) is needed...
  11. ncbi request reprint Report of the Pathology Committee: false-positive and false-negative diagnoses of prostate cancer
    T H Van der Kwast
    Department of Pathology, Josephine Nefkens Institute, Erasmus Medical Center, Rotterdam, The Netherlands
    BJU Int 92:62-5. 2003
  12. pmc Guidelines for processing and reporting of prostatic needle biopsies
    Th H van der Kwast
    Department of Pathology, Erasmus Medical Center, 3000 DR Rotterdam, The Netherlands
    J Clin Pathol 56:336-40. 2003
    ..The definition of parameters for quality control of prostatic needle biopsy diagnostics will further facilitate clinical epidemiological multicentre studies of prostate cancer...
  13. ncbi request reprint [Diagnosis based on prostate needle biopsy: inadequate correlation between pathologic results and clinical course for individual prognosis]
    Th H van der Kwast
    Mount Sinai Hospital, Toronto, M5G 1X5 Canada
    Ned Tijdschr Geneeskd 149:972-6. 2005
    ....